UBS Group’s Rayliant Quantamental China Equity ETF RAYC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-200
| Closed | -$3.68K | – | 11056 |
|
|
2025
Q3 | $3.68K | Sell |
200
-63,080
| -100% | -$1.05M | ﹤0.01% | 9025 |
|
|
2025
Q2 | $947K | Sell |
63,280
-1,802
| -3% | -$25.8K | ﹤0.01% | 5495 |
|
|
2025
Q1 | $939K | Buy |
65,082
+12,937
| +25% | +$184K | ﹤0.01% | 5329 |
|
|
2024
Q4 | $736K | Sell |
52,145
-2,220
| -4% | -$33.9K | ﹤0.01% | 5558 |
|
|
2024
Q3 | $856K | Buy |
54,365
+2,815
| +5% | +$37K | ﹤0.01% | 4785 |
|
|
2024
Q2 | $691K | Buy |
51,550
+30,496
| +145% | +$425K | ﹤0.01% | 4746 |
|
|
2024
Q1 | $283K | Sell |
21,054
-6,097
| -22% | -$78.6K | ﹤0.01% | 5608 |
|
|
2023
Q4 | $348K | Sell |
27,151
-5,290
| -16% | -$72K | ﹤0.01% | 5393 |
|
|
2023
Q3 | $469K | Buy |
32,441
+3,538
| +12% | +$52.6K | ﹤0.01% | 4697 |
|
|
2023
Q2 | $442K | Buy |
28,903
+2,947
| +11% | +$47.9K | ﹤0.01% | 4923 |
|
|
2023
Q1 | $448K | Buy |
25,956
+21,753
| +518% | +$393K | ﹤0.01% | 4782 |
|
|
2022
Q4 | $71.8K | Buy |
+4,203
| New | +$73.7K | ﹤0.01% | 6421 |
|
|
2022
Q3 | – | Sell |
-14
| Closed | – | – | 10813 |
|
|
2022
Q2 | $0 | Sell |
14
-1,331
| -99% | -$27.3K | ﹤0.01% | 10813 |
|
|
2022
Q1 | $30K | Buy |
1,345
+1,321
| +5,504% | +$31K | ﹤0.01% | 7007 |
|
|
2021
Q4 | $1K | Buy |
+24
| New | +$608 | ﹤0.01% | 10025 |
|
UBS Group's RAYC Position: Q4 2025 in Review
UBS Group sold out of Rayliant Quantamental China Equity ETF (RAYC) in Q4 2025, closing a stake of 200 shares — an estimated $3.68K sold.
UBS Group first reported a position in RAYC in Q4 2021 and held it in 15 quarters. The position peaked at $947K in Q2 2025. 0 funds tracked by Wall St. Rank hold RAYC as of Q4 2025.
- UBS Group reported no remaining Rayliant Quantamental China Equity ETF position as of Q4 2025 after selling out during the quarter.
- UBS Group sold 200 Rayliant Quantamental China Equity ETF shares in Q4 2025, an estimated $3.68K.
- UBS Group first reported a position in Rayliant Quantamental China Equity ETF in Q4 2021 and held it in 15 quarters.
- UBS Group's Rayliant Quantamental China Equity ETF position peaked at $947K in Q2 2025.
- 0 funds tracked by Wall St. Rank held Rayliant Quantamental China Equity ETF as of Q4 2025.
Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.